MARKET

APM

APM

Aptorum Group Ltd
NASDAQ
0.7000
+0.0076
+1.10%
Suspension 19:46 07/17 EDT
OPEN
0.7006
PREV CLOSE
0.6924
HIGH
0.7490
LOW
0.6000
VOLUME
195.15K
TURNOVER
--
52 WEEK HIGH
4.470
52 WEEK LOW
0.6000
MARKET CAP
5.70M
P/E (TTM)
-3.7756
1D
5D
1M
3M
1Y
5Y
1D
Aptorum Group Ltd trading halted, news pending
TipRanks · 1d ago
Aptorum provide update on DiamiR merger, announces 1-for-10 reverse stock split
TipRanks · 3d ago
Aptorum Group Announces 1-For-10 Reverse Stock Split, Effective July 20; Proposed Merger With DiamiR Biosciences Anticipated To Close Around July 20
Benzinga · 3d ago
*Aptorum Group Announces 1-for-10 Reverse Share Split, Delaware Redomestication in Connection With the Merger >APM
Dow Jones · 3d ago
Aptorum Group plans 1-for-10 reverse stock split ahead of DiamiR merger
PUBT · 3d ago
APTORUM GROUP PROVIDES UPDATE ON DIAMIR BIOSCIENCES MERGER
Reuters · 3d ago
Weekly Report: what happened at APM last week (0706-0710)?
Weekly Report · 6d ago
Aptorum, DiamiR set to close all-stock merger before fiscal 2027, rebrand as Niki BioSolutions
PUBT · 07/08 12:04
More
About APM
Aptorum Group Limited is a United Kingdom-based clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The Company's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.

Webull offers Aptorum Group Ltd stock information, including NASDAQ: APM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APM stock methods without spending real money on the virtual paper trading platform.